Main Menu
Main Menu
Stay updated with news and stories of strength and hope. Learn how biomarker testing is unlocking personalized treatment options and how clinical trials are offering new paths forward.
MyTumorID: ID Your Tumor. ID Your Options. A brain tumor diagnosis can feel overwhelming, but knowledge is key to making informed decisions about care. Biomarker testing helps uncover critical details about a tumor’s genetic makeup, which can open doors to targeted treatments and clinical trials. In this video, brain tumor community members and experts explain why understanding your tumor through biomarker testing […] February 18, 2025
Unlocking Better Outcomes: Melissa’s Advocacy for Biomarker Testing and Brain Cancer Research Last month, Melissa F. and her partner Jess E. arrived bright and early to help set up for the Race for Hope Greater Philadelphia, an event that has become deeply personal to them both. For Melissa, it’s a way to give back to the community that has supported them since Jess’s brain tumor recurrence in […] November 8, 2024
New Brain Tumor Clinical Trials: April – October 2024 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients. This report provides a summary of the studies that have recently opened or started recruiting since our last report for patients with a primary brain tumor. Follow the hyperlink for […] November 7, 2024
Q&A with a Pathologist (Part Two): Keith Ligon, MD, PhD The team at the National Brain Tumor Society interviewed Keith Ligon, MD, PhD, in part one of our series to help explain pathology and biomarker testing as part of NBTS’s MyTumorID campaign. NBTS launched the MyTumorID campaign this year to educate and empower patients and care partners to make informed decisions about biomarker testing and clinical […] October 7, 2024
Q&A with a Pathologist (Part One): Keith Ligon, MD, PhD The most recent WHO Classification of Tumours emphasizes the importance of biomarker testing in the diagnosis of brain tumors, yet nearly 70% of patients with brain tumors reported not understanding what biomarker testing is in a recent survey. National Brain Tumor Society launched the MyTumorID campaign this year to educate and empower patients and care […] August 27, 2024
Have you undergone biomarker testing for your brain tumor or enrolled in a clinical trial? NBTS wants to hear from you!